Terms: = Germ cell tumor AND DEK, D6S231E, 7913, ENSG00000124795, P35659 AND Treatment
4 results:
1. Identification of a tumor cell Associated Type I IFN Resistance Gene Expression Signature of Human Melanoma, the Components of Which Have a Predictive Potential for Immunotherapy.
Ladányi A; Rásó E; Barbai T; Vízkeleti L; Puskás LG; Kovács SA; Győrffy B; Tímár J
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269844
[TBL] [Abstract] [Full Text] [Related]
2. Phosphoproteomics of Retinoblastoma: A Pilot Study Identifies Aberrant Kinases.
Selvan LDN; Danda R; Madugundu AK; Puttamallesh VN; Sathe GJ; Krishnan UM; Khetan V; Rishi P; Prasad TSK; Pandey A; Krishnakumar S; Gowda H; Elchuri SV
Molecules; 2018 Jun; 23(6):. PubMed ID: 29914080
[TBL] [Abstract] [Full Text] [Related]
3. dek proto-oncogene is highly expressed in astrocytic tumors and regulates glioblastoma cell proliferation and apoptosis.
Feng T; Liu Y; Li C; Li Z; Cai H
Tumour Biol; 2017 Jul; 39(7):1010428317716248. PubMed ID: 28670979
[TBL] [Abstract] [Full Text] [Related]
4. The identification of novel therapeutic targets for the treatment of malignant brain tumors.
Kroes RA; Jastrow A; McLone MG; Yamamoto H; Colley P; Kersey DS; Yong VW; Mkrdichian E; Cerullo L; Leestma J; Moskal JR
Cancer Lett; 2000 Aug; 156(2):191-8. PubMed ID: 10880769
[TBL] [Abstract] [Full Text] [Related]
